Guru Ownership Trend
Guru Analysis for Dianthus Therapeutics, Inc. (DNTH)
Dianthus Therapeutics, Inc. (DNTH), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $30.85 M.
Top institutional holders include Jefferies Group and Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $49.44 M net outflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position. Conversely, Cliff Asness reduced exposure by 27.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Dianthus Therapeutics, Inc. (DNTH)
Major holders include Jefferies Group ($16.99 M), Paul Tudor Jones ($3.64 M), Ken Fisher ($2.28 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 266,045 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $49.44 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited DNTH. The total reported sell value was $54.12 M.
Yes, 1 managers opened new positions in DNTH, and 1 increased their existing holdings. The total reported buy value was $4.68 M.